Senhwa Biosciences (6492) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 生華科

Senhwa Biosciences (6492) reported revenue of NT$80,000 for Oct 2026, +0.0% year on year and +0.0% from the previous month. Revenue for Jan–Oct 2026 was NT$800,000 (-12.1% year on year).

In Oct 2026, it ranked No. 151 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$83,00024/10Nov 2024 NT$83,000Dec 2024 NT$84,000Jan 2025 NT$83,000Feb 2025 NT$84,00025/02Mar 2025 NT$83,000Apr 2025 NT$83,000May 2025 NT$83,000Jun 2025 NT$84,00025/06Jul 2025 NT$83,000Aug 2025 NT$83,000Sep 2025 NT$164,000Oct 2025 NT$80,00025/10Nov 2025 NT$80,000Dec 2025 NT$80,000Jan 2026 NT$80,000Feb 2026 NT$80,00026/02Mar 2026 NT$80,000Apr 2026 NT$80,000May 2026 NT$80,000Jun 2026 NT$80,00026/06Jul 2026 NT$80,000Aug 2026 NT$80,000Sep 2026 NT$80,000Oct 2026 NT$80,00026/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$80,000+0.0%+0.0%
Sep 2026NT$80,000-51.2%+0.0%
Aug 2026NT$80,000-3.6%+0.0%
Jul 2026NT$80,000-3.6%+0.0%
Jun 2026NT$80,000-4.8%+0.0%
May 2026NT$80,000-3.6%+0.0%
Apr 2026NT$80,000-3.6%+0.0%
Mar 2026NT$80,000-3.6%+0.0%
Feb 2026NT$80,000-4.8%+0.0%
Jan 2026NT$80,000-3.6%+0.0%
Dec 2025NT$80,000-4.8%+0.0%
Nov 2025NT$80,000-3.6%+0.0%
Oct 2025NT$80,000-3.6%-51.2%
Sep 2025NT$164,000+95.2%+97.6%
Aug 2025NT$83,000+0.0%+0.0%
Jul 2025NT$83,000+0.0%-1.2%
Jun 2025NT$84,000+0.0%+1.2%
May 2025NT$83,000+0.0%+0.0%
Apr 2025NT$83,000+0.0%+0.0%
Mar 2025NT$83,000+0.0%-1.2%
Feb 2025NT$84,000+0.0%+1.2%
Jan 2025NT$83,000+0.0%-1.2%
Dec 2024NT$84,000+0.0%+1.2%
Nov 2024NT$83,000+0.0%+0.0%
Oct 2024NT$83,000+0.0%-1.2%

Jan–Oct 2026 cumulative: NT$800,000 (-12.1% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Senhwa Biosciences vs PEC / Senhwa Biosciences vs Lotus Pharm / Senhwa Biosciences vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16